Patents by Inventor Ryan Kalb

Ryan Kalb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12385022
    Abstract: The invention involves the provision of recombinant algal mutants that have a genetic modification to a nucleic acid sequence encoding a trehalose biosynthetic enzyme, and/or a genetic modification to a nucleic acid encoding an RNA binding domain And in some embodiments either of these algal mutants can further have a genetic mutation to a nucleic acid sequence encoding an SGI1 polypeptide. Attenuation of one, two, or all three of these genes results in a mutant organism with increased lipid productivity. It was also discovered that one, two, three, or more genetic mutations can be accumulated or “stacked” in a particular mutant cell or organism to result in further increases in the production of lipid products. The lipid products of these mutants are useful as biofuels or for other specialty chemical products.
    Type: Grant
    Filed: December 28, 2023
    Date of Patent: August 12, 2025
    Assignee: Viridos, Inc.
    Inventors: Eric R. Moellering, Saheed Imam, Luke Peach, Ryan Kalb, Sarah Potts
  • Publication number: 20240332728
    Abstract: A battery fire suppression system comprising one or more battery packs; one or more sensors disposed internal to the one or more battery packs; a fire suppressant deployment system; a controller, one or more software modules that, when executed by the controller, receive one or more signals from the one or more sensors indicative of one or more conditions internal to the one or more battery packs; actuate the fire suppressant deployment system to deploy a fire suppressant to suppress a fire or possible fire in the one or more battery packs if the one or more signals are indicative of a thermal runaway in the one or more battery packs.
    Type: Application
    Filed: April 3, 2024
    Publication date: October 3, 2024
    Inventors: Ryan Kalb, Jacob Hawksworth
  • Publication number: 20240124858
    Abstract: The invention involves the provision of recombinant algal mutants that have a genetic modification to a nucleic acid sequence encoding a trehalose biosynthetic enzyme, and/or a genetic modification to a nucleic acid encoding an RNA binding domain And in some embodiments either of these algal mutants can further have a genetic mutation to a nucleic acid sequence encoding an SGI1 polypeptide. Attenuation of one, two, or all three of these genes results in a mutant organism with increased lipid productivity. It was also discovered that one, two, three, or more genetic mutations can be accumulated or “stacked” in a particular mutant cell or organism to result in further increases in the production of lipid products. The lipid products of these mutants are useful as biofuels or for other specialty chemical products.
    Type: Application
    Filed: December 28, 2023
    Publication date: April 18, 2024
    Inventors: Eric R. Moellering, Saheed Imam, Luke Peach, Ryan Kalb, Sarah Potts
  • Patent number: 11859218
    Abstract: The invention involves the provision of recombinant algal mutants that have a genetic modification to a nucleic acid sequence encoding a trehalose biosynthetic enzyme, and/or a genetic modification to a nucleic acid encoding an RNA binding domain. And in some embodiments either of these algal mutants can further have a genetic mutation to a nucleic acid sequence encoding an SGI1 polypeptide. Attenuation of one, two, or all three of these genes results in a mutant organism with increased lipid productivity. It was also discovered that one, two, three, or more genetic mutations can be accumulated or “stacked” in a particular mutant cell or organism to result in further increases in the production of lipid products. The lipid products of these mutants are useful as biofuels or for other specialty chemical products.
    Type: Grant
    Filed: December 16, 2020
    Date of Patent: January 2, 2024
    Assignee: Viridos, Inc.
    Inventors: Eric R. Moellering, Saheed Imam, Luke Peach, Ryan Kalb, Sarah Potts
  • Publication number: 20210180036
    Abstract: The invention involves the provision of recombinant algal mutants that have a genetic modification to a nucleic acid sequence encoding a trehalose biosynthetic enzyme, and/or a genetic modification to a nucleic acid encoding an RNA binding domain. And in some embodiments either of these algal mutants can further have a genetic mutation to a nucleic acid sequence encoding an SGI1 polypeptide. Attenuation of one, two, or all three of these genes results in a mutant organism with increased lipid productivity. It was also discovered that one, two, three, or more genetic mutations can be accumulated or “stacked” in a particular mutant cell or organism to result in further increases in the production of lipid products. The lipid products of these mutants are useful as biofuels or for other specialty chemical products.
    Type: Application
    Filed: December 16, 2020
    Publication date: June 17, 2021
    Inventors: Eric R. Moellering, Saheed Imam, Luke Peach, Ryan Kalb, Sarah Potts